Table 2.
Antimicrobial profiling of the compound myricetin
| Strains | Results | References |
|---|---|---|
| Antiviral | ||
| HIV Reverse Transcriptase | 0.08 a | [43] |
| HIV Reverse Transcriptase, Moloney murine leukemia virus | 0.08 b | [53] |
| Antimicrobial | ||
| Gram positive | ||
| Actinomyces viscosus | 20 b | [54] |
| Burkholderia cepacia | >512 b | [55] |
| Corynebacterium diphtheriticum | 18.2 e | [56] |
| Enterococcus faecalis | 17.0 e | [56] |
| Enterococcus faecalis 2400 | 17.0 e | [56] |
| Enterococcus faecium | 16.8 e | [56] |
| Methicillin-resistant Staphylococcus aureus | 256 b | [55] |
| Staphylococcus aureus ATCC6538p | > 300 c | [57] |
| Staphylococcus aureus | > 2000 b | [58] |
| Staphylococcus epidermidis ATCC14490 | 64 b | [55] |
| Staphylococcus epidermidis | > 2000 b | [58] |
| Staphylococcus epidermidis | 17.4 e | [56] |
| Staphylococcus saprophyticus | 17.6 e | [56] |
| Streptococcus mutans | 20 b | [54] |
| Streptococcus pneumoniae 49 | 128 b | [55] |
| Streptococcus pneumoniae | 17.4 e | [56] |
| Streptococcus pyogenes | 16.4 e | [56] |
| Vancomycin-Resistant Enterococci (VRE) | 512 | [55] |
| Gram negative | ||
| Burkholderia cepacia | 64 b | [55] |
| Enterobacter aerogenes | 256 b | [55] |
| Escherichia coli | > 2000 b | [58] |
| Escherichia coli WT | 12.2 e | [56] |
| Escherichia coli BU40 | 12.6 e | [56] |
| Escherichia coli FPL5014 | 11.6 e | [56] |
| Escherichia coli DnaB helicase | 11.3 d | [42] |
| Klebsiella pneumoniae ATCC13883 | 64 b | [55] |
| Klebsiella pneumoniae | 128 b | [59] |
| Klebsiella pneumoniae | > 2000 b | [58] |
| Klebsiella pneumoniae | 16.6 e | [56] |
| Porphyromonas gingivalis | 2500 b | [54] |
| Prevotella intermedia | 1250 b | [54] |
| Proteus mirabilis | 16.5 e | [56] |
| Pseudomonas aeruginosa ATCC27853 | 256 b | [55] |
| Pseudomonas aeruginosa | > 2000 b | [58] |
| Pseudomonas aeruginosa PAO286 | 15.6 e | [56] |
| Salmonella paratyphi A | 14.4 e | [56] |
| Salmonella paratyphi B | 14.4 e | [56] |
| Salmonella typhi | 14.4 e | [56] |
| Shigella dysenteriae | 15.5 e | [56] |
| Shigella flexneri | 13.4 e | [56] |
| Shigella sonnei | 14.6 e | [56] |
| Anti-chlamydial | ||
| Chlamydia pneumoniae | 29 c | [60] |
Microbial strain is inserted when microbial type is repeated and information available
aKi (μM)
bminimum inhibitory concentration (MIC, μg/mL)
cMIC (μM)
dhalf maximal inhibitory concentration (IC50, μM)
ezone of inhibition (ZOI, mm) for 100 μL of 0.5 mg/mL myricetin